INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 59 filers reported holding INSTIL BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -99.8% | 57 | -99.7% | 0.00% | – |
| Q2 2023 | $9,633 | -83.8% | 17,483 | -80.6% | 0.00% | – |
| Q1 2023 | $59,434 | -99.2% | 89,942 | -99.3% | 0.00% | -100.0% |
| Q4 2022 | $7,752,537 | -91.8% | 12,305,616 | -36.7% | 0.00% | -90.0% |
| Q3 2022 | $94,157,000 | +5.1% | 19,454,035 | +0.3% | 0.01% | +11.1% |
| Q2 2022 | $89,581,000 | -54.1% | 19,389,766 | +6.9% | 0.01% | -43.8% |
| Q1 2022 | $194,981,000 | -23.5% | 18,137,713 | +21.8% | 0.02% | -15.8% |
| Q4 2021 | $254,857,000 | +14.5% | 14,895,240 | +19.6% | 0.02% | +5.6% |
| Q3 2021 | $222,668,000 | +9.1% | 12,456,936 | +15.8% | 0.02% | +12.5% |
| Q2 2021 | $204,165,000 | +20.4% | 10,758,361 | +50.6% | 0.02% | +14.3% |
| Q1 2021 | $169,609,000 | – | 7,144,389 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
| CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
| Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
| Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
| Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
| Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
| HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
| Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |